The mission of the Bioanalytics, Metabolomics & Pharmacokinetics (BMPK) Shared Resource is to support clinical research and clinical/pre-clinical drug development at RPCI as well as providing bioanalytical and consultation services to industry. BMPK provides state-of-the-art analytical scientific data PK studies of cancer therapeutic and preventive agents. In addition, our group advises investigators on PK/PD study design, sample collection and handling as well as dose selection to optimize the therapeutic window of oncology drug products.
The BMPK Shared Resource provides complete services to investigators, ranging from study design consultation and methodology development, to storage, preparation and assay of samples, and data analysis. The Resource offers a wide variety of analytical assays along with the capabilities to develop and validate new methods. Using state-of-the-art techniques with LC/MS/MS, UPLC, HPLC, and Atomic Absorption spectrophotometry, the BMPK provides highly sensitive measurements for a wide array of chemotherapeutic agents and metabolite. Please see the attached file below for a rescent listing of key contributions the BMPK resource has provided to RPCI and the local research community.
Roswell Park Cancer Institute
BMPK Shared Resource
CGP, Room L1-140
Elm and Carlton Streets
Buffalo, New York 14263
Monday – Friday, 8 a.m. – 5 p.m.
Core Grant Citation
This shared resource is funded by NCI P30CA16056. Publications should cite the Core grant in the acknowledgment section, if publications use data generated by the shared resource. Two copies of the publication acknowledging the Core grant should also be submitted to the facility at Elm & Carlton Streets, Buffalo NY, 14263.